JP2015500293A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500293A5
JP2015500293A5 JP2014546080A JP2014546080A JP2015500293A5 JP 2015500293 A5 JP2015500293 A5 JP 2015500293A5 JP 2014546080 A JP2014546080 A JP 2014546080A JP 2014546080 A JP2014546080 A JP 2014546080A JP 2015500293 A5 JP2015500293 A5 JP 2015500293A5
Authority
JP
Japan
Prior art keywords
neuropeptide
receptor antagonist
pharmaceutical composition
aryl
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014546080A
Other languages
English (en)
Japanese (ja)
Other versions
JP6381445B2 (ja
JP2015500293A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/068257 external-priority patent/WO2013086200A1/en
Publication of JP2015500293A publication Critical patent/JP2015500293A/ja
Publication of JP2015500293A5 publication Critical patent/JP2015500293A5/ja
Application granted granted Critical
Publication of JP6381445B2 publication Critical patent/JP6381445B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014546080A 2011-12-08 2012-12-06 ニューロペプチドsレセプター(npsr)アンタゴニストの組成物および方法 Active JP6381445B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161568540P 2011-12-08 2011-12-08
US61/568,540 2011-12-08
PCT/US2012/068257 WO2013086200A1 (en) 2011-12-08 2012-12-06 Composition and method for neuropeptide s receptor (npsr) antagonists

Publications (3)

Publication Number Publication Date
JP2015500293A JP2015500293A (ja) 2015-01-05
JP2015500293A5 true JP2015500293A5 (cg-RX-API-DMAC7.html) 2015-12-24
JP6381445B2 JP6381445B2 (ja) 2018-08-29

Family

ID=48574884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014546080A Active JP6381445B2 (ja) 2011-12-08 2012-12-06 ニューロペプチドsレセプター(npsr)アンタゴニストの組成物および方法

Country Status (7)

Country Link
US (1) US9150582B2 (cg-RX-API-DMAC7.html)
EP (1) EP2788359B1 (cg-RX-API-DMAC7.html)
JP (1) JP6381445B2 (cg-RX-API-DMAC7.html)
AU (1) AU2012347758B2 (cg-RX-API-DMAC7.html)
CA (1) CA2858571C (cg-RX-API-DMAC7.html)
ES (1) ES2624853T3 (cg-RX-API-DMAC7.html)
WO (1) WO2013086200A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11142546B2 (en) 2016-04-04 2021-10-12 Research Triangle Institute Neuropeptide S receptor (NPSR) agonists
JOP20190060A1 (ar) * 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917489B1 (cg-RX-API-DMAC7.html) * 1970-01-22 1974-05-01
DE3469531D1 (en) * 1983-09-15 1988-04-07 Ciba Geigy Ag 5- and 6-azaphthalides, their mixture of isomers, process for their production and their use in recording materials which are sensitive to pressure and heat
JPH06502628A (ja) * 1990-11-22 1994-03-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 除草作用をもつイソニコチン酸誘導体および関係するスピロ化合物
AU2001294239A1 (en) 2000-10-13 2002-04-22 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
AU2002246983A1 (en) * 2001-01-11 2002-07-24 Bristol-Myers Squibb Pharma Company 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
US9012407B2 (en) * 2004-04-23 2015-04-21 The Regents Of The University Of California Therapies which act on neuropeptide S receptors
US8541595B2 (en) * 2008-11-13 2013-09-24 Merch Sharp & Dohme Corp. Imidazoisoindole neuropeptide S receptor antagonists
US8389720B2 (en) * 2008-11-13 2013-03-05 Merck Sharp & Dohme Corp. Quinolone neuropeptide S receptor antagonists

Similar Documents

Publication Publication Date Title
TWI404721B (zh) 胺基-雜環化合物
KR100197454B1 (ko) 디아자비시클릭 뉴로키닌 길항제
TW200427690A (en) Opioid and opioid-like compounds and uses thereof
JP2011500638A5 (cg-RX-API-DMAC7.html)
KR20170131650A (ko) 글루타미나제 억제제의 투여 방법
JP5421108B2 (ja) 2−フェノキシピリミジノン類縁体
RU2264401C3 (ru) Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения и промежуточные вещества
JP2010503688A5 (cg-RX-API-DMAC7.html)
RU2014123434A (ru) Фармацевтические соединения
JP2008513498A5 (cg-RX-API-DMAC7.html)
ZA200302918B (en) Combination use of acetylcholinesterase inhibitors and gabaa inverse agonists for the treatment of cognitive disorders.
JP2013231086A (ja) 化学療法の強化方法
CN101868447A (zh) 制备和施用作为抗癌剂的喹啉衍生物的方法
US20130158035A1 (en) Antimetastatic compounds
US20080032965A1 (en) Method for enhancing cognitive function
CN100586434C (zh) 止痒剂
JP2004175809A (ja) 哺乳動物における嗜癖性障害および神経障害または精神障害の治療用医薬組成物
WO2005102388A1 (ja) 新規なblt2介在性疾患、blt2結合剤および化合物
TW200808741A (en) 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
JP2015500293A5 (cg-RX-API-DMAC7.html)
JP2021511338A (ja) 睡眠障害の治療及び予防
US20160152617A1 (en) Compounds for the treatment of malaria
CZ285481B6 (cs) 6-(2-imidazolinylamino)chinolinové sloučeniny použitelné jako alfa-2-adrenoceptorové agonisté
ITMI951900A1 (it) Derivati idroisochinolinici sostituiti
JPH10502657A (ja) ヘテロ環縮合モルヒノイド誘導体